Cargando…
Hyperkalemia in women with acne exposed to oral spironolactone: A retrospective study from the RADAR (Research on Adverse Drug Events and Reports) program()
PURPOSE: The necessity of serum potassium monitoring for healthy women who are prescribed spironolactone for acne has been debated. The aim of this study was to compare the incidence of hyperkalemia in women 18 to 45 years of age to that in women 46 to 65 years of age, when treated with oral spirono...
Autores principales: | Thiede, Rebecca M., Rastogi, Supriya, Nardone, Beatrice, Sadowsky, Lauren M., Rangel, Stephanie M., West, Dennis P., Schlosser, Bethanee J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637080/ https://www.ncbi.nlm.nih.gov/pubmed/31360748 http://dx.doi.org/10.1016/j.ijwd.2019.04.024 |
Ejemplares similares
-
Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia
por: Bounthavong, Mark, et al.
Publicado: (2018) -
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women
por: Renz, Susanne, et al.
Publicado: (2021) -
Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review
por: Layton, Alison M., et al.
Publicado: (2017) -
Spironolactone for the treatment of acne in women, a retrospective study of 110 patients()()()
por: Charny, J.W., et al.
Publicado: (2017) -
Treatment of Acne Vulgaris by Topical Spironolactone Solution Compared With Clindamycin Solution
por: Noaimi, Adil, et al.
Publicado: (2021)